Gardasil 9. "In response to calls from scientific leaders for more clinical data concerning alternative dosing regimens for Gardasil 9, Merck, pending regulatory input, plans to conduct two ...
The continued decline of Merck & Co.’s HPV vaccine Gardasil in China has come to a head as the New Jersey drug giant is ...
Merck (MRK) anticipates full-year 2025 sales to be between $64.1B-$65.6B, including a negative impact of foreign exchange of approximately 2% ...